The Australian Financial Complaints Authority (AFCA) has ordered HDI Global Specialty to pay a travel cancellation claim.
The ombudsman found that a pregnancy complication which ended in miscarriage was diagnosed after the policy’s waiting period had ended.
The policy’s certificate of insurance was issued on December 7 last year. It carried a 72-hour waiting period, ending on December 10, during which events leading to cancellation fees or lost deposits were excluded.
One of the policyholders experienced spotting on December 8. On December 11, an ultrasound with her midwife showed the pregnancy was not viable, and she was certified unfit to travel. A miscarriage was confirmed on December 15. The couple rescheduled their trip and claimed amendment fees and lost deposits.
HDI declined the claim. It argued the spotting on 8 December was most likely the first sign of the same condition that led to the diagnosis, which placed the event inside the waiting period.
The complainants argued that spotting without pain, cramping or other worrying signs does not necessarily indicate a non-viable pregnancy.
AFCA agreed with them. It found the complainant had not been diagnosed with a condition requiring immediate treatment, or certified unfit to travel, until December 11.
“The spotting is, by itself, not sufficient to trigger the cancellation or amendment cover under the policy,” the ombudsman said.
HDI must settle the claim under the policy’s terms and conditions.
The ruling follows an earlier AFCA determination involving the same insurer. In that case, a traveller saw a GP with flu-like symptoms during a 72-hour waiting period, and HDI argued the visit was the claimable event. AFCA found instead that the event was the later diagnosis and certificate of unfitness to travel.
Together, the two decisions give a consistent reading of wordings that make cover depend on a medical adviser certifying someone unfit to travel. Where the policy works that way, AFCA treats the certification as the trigger, not the first symptom that later turns out to be connected.
Insurers using similar waiting period clauses may need to revisit how they apply them at claims stage. The rulings indicate that arguing a symptom is “most likely” linked to a later diagnosis will not succeed where the policy’s own trigger is a medical certification. For consumers buying cover shortly before departure, the decisions also offer some reassurance: a minor symptom in the first days of a policy will not necessarily rule out a later claim.